ClinicalTrials.gov
ClinicalTrials.gov Menu

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects (SWEAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02042001
Recruitment Status : Unknown
Verified January 2014 by Giuseppe Lapadula, Azienda Ospedaliera San Gerardo di Monza.
Recruitment status was:  Not yet recruiting
First Posted : January 22, 2014
Last Update Posted : January 22, 2014
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Giuseppe Lapadula, Azienda Ospedaliera San Gerardo di Monza

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2015
  Study Completion Date : No date given